Prices are updated after-hours

Manufacturing 2022 - 05 - 20

IM Cannabis Corp

IMCC | $0.611 -15.93% -18.95% 600K

|

(0.0% 1d) (203.3% 1m) (38.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-62.84% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 8,181,016
https://imcannabis.com
Sec Filling | Patents | 2020 employees

IMC is an MCO in the medical cannabis sector headquartered in Israel and with operations In Israel and Germany. Over the past decade, the Company believes that the IMC brand has become synonymous with quality and consistency in the Israeli medical cannabis market. The Company has also expanded its business to offer intellectual property-related services to the medical cannabis industry. In Europe, IMC operates through Adjupharm GmbH ("Adjupharm"), a German-based subsidiary and EU-GMP certified medical cannabis distributor. IMC's European presence is augmented by strategic alliances with various pan-European EU-GMP cultivators and distributors to capitalize on the increased demand for medical cannabis products in Europe and bring the IMC brand and its product portfolio to European patients.

israel brands cannabis

add to watch list Paper trade email alert is off

Lithium & Boron Technology, Inc.

LBTI | $0.0002 424900.0% 130

|

(0.0% 1d) (0.0% 1m) (-90.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-98.99% volume)
Earnings Calendar:
Market Cap: $ 37,194

Sec Filling | Patents | 153 employees

add to watch list Paper trade email alert is off

ADVANCED CONTAINER TECHNOLOGIES, INC.

ACTX | $0.0001 249900.0% 42K

|

(0.0% 1d) (0.0% 1m) (-100.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (3672.4% volume)
Earnings Calendar:
Market Cap: $ 5,193

Sec Filling | Patents | 6 employees

advanced container technologies inc. engages in designing, manufacturing, and selling plastic medical grade containers. the company is based in corona, california.

add to watch list Paper trade email alert is off

ALR TECHNOLOGIES INC.

ALRT | $0.0297

|

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (-0.3% 3d) (0.0% 7d) (-93.07% volume)
Earnings Calendar:
Market Cap: $ 16,393,415
http://www.alrt.com
Sec Filling | Patents | 1 employees

(United States)

add to watch list Paper trade email alert is off

Biostage, Inc.

BSTG 4 | $4.03 67.25% 4.5K

|

(0.0% 1d) (0.0% 1m) (-33.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-3.86% volume)
Earnings Calendar:
Market Cap: $ 55,944,702

Sec Filling | Patents | 7 employees

biostage, inc. (otcqb: bstg) is a pioneering biotechnology company developing bioengineered organ implants to address unmet needs in the treatment of life-threatening cancer, traumas and congenital abnormalities of the esophagus, bronchus and trachea. the company’s cellframe™ technology platform is engineered to stimulate the body’s signaling pathways and natural healing process to regenerate and restore organ function. combining a synthetic scaffold with tissue engineering and cell biology, biostage’s cellframe™ platform is used to create organ specific cellspan™ implants. the cellspan™ implant is delivered directly to the site where tissue regeneration is needed, and has been designed to promote in situ tissue regeneration by providing both stem cell-derived biological signals, and three-dimensional guidance and support for cell growth differentiation. recent large animal data delivered promising results as cellframe™-based cellspan™ implants applied to the esophagus achieved regener

t-cell

add to watch list Paper trade email alert is off

INTERNATIONAL BALER CORP

IBAL 4 | $1.69 1.18%

|

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (183.11% volume)
Earnings Calendar:
Market Cap:

Sec Filling | Patents | 49 employees

add to watch list Paper trade email alert is off

NUTRA PHARMA CORP

NPHC | $0.0001 2900.0% 3

|

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-99.81% volume)
Earnings Calendar:
Market Cap: $ 706,474

Sec Filling | Patents | 4 employees

nutra pharma corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. the company carries out basic drug discovery research and clinical development, and also seeks strategic licensing partnerships to reduce the risks associated with the drug development process. currently, nutra pharma offers several drug products for sale for the treatment of pain: nyloxin, the first over-the-counter (otc) pain reliever clinically proven to treat moderate to severe (stage 2) chronic pain, and nyloxin extra strength, the only non-narcotic and non-addictive treatment for severe (stage 3) pain. see: www.nyloxin.com nutra pharma also offers pet pain-away: a product aimed at treating moderate to severe chronic pain in companion animals. pet pain-away is specifically indicated to treat pain from hip dysplasia, arthrit

education

add to watch list Paper trade email alert is off

Ever Harvest International Group Inc.

TLGN | $0.0004 36150.0% 200

|

(0.0% 1d) (0.0% 1m) (-97.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-90.0% volume)
Earnings Calendar:
Market Cap: $ 204,329

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

Purthanol Resources Ltd

PURT | $0.0035

|

(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (0.0% volume)
Earnings Calendar:
Market Cap: $ 854,136

Sec Filling | Patents | 4 employees

purthanol has been at the forefront of research & development for solutions to the problems of co2 emissions and deforestation, which the united nations has determined are the two main contributors to global warming. over the past several years we have advanced our technologies and proprietary knowledge past the proof of concept stage and are presently in the process of commencing large scale production of both our ethanol and biodiesel divisions. purthanol’s ethanol production is highly profitable with a pre tax gross profit margin of 60% or more, in fact our feedstock is capable of generating up to three harvests per year in tropical locations while we have based our revenue projections on only two crops per year. purthanol biofuel’s mission is to provide useful products from disposed commodities. waste fryer grease converted into a clean burning replacement for diesel (biodiesel) will be the first of several recycling processes that produces biofuels. expansion into the procurem

profitable

add to watch list Paper trade email alert is off

RLX Technology Inc - ADR

RLX | $1.775 -1.93% 0.0% 4.2M

|

(0.0% 1d) (-15.6% 1m) (-32.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-28.39% volume)
Earnings Calendar:
Market Cap: $ 2,240,184,155
https://www.relxtech.com
Sec Filling | Patents | 2020 employees

(China (Mainland)) RLX Technology Inc. is a leading branded e-vapor company in China. RLX leverages its strong in-house technology and product development capabilities and in-depth insights into adult smokers' needs to develop superior e-vapor products. To holistically improve adult smokers' experience with its products, RLX has implemented a multi-layered development framework that encompasses accessories, interactions, applications, phase-transitions and infrastructure. RLX Technology sells its products through an integrated offline distribution and

housing brands

add to watch list Paper trade email alert is off

Edgewise Therapeutics Inc

EWTX | $15.23 -1.42% -1.44% 540K

|

(0.0% 1d) (-0.8% 1m) (138.9% 1y) (0.0% 2d) (0.0% 3d) (0.9% 7d) (39.07% volume)
Earnings Calendar: 2023-11-02
Market Cap: $ 1,418,074,788
https://edgewisetx.com
Sec Filling | Patents | n/a employees

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Guided by its holistic drug discovery approach to targeting the muscle as an organ, Edgewise has combined its foundational expertise in muscle biology and small molecule engineering to build its proprietary, muscle focused drug discovery platform. Edgewise’s platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases.

drug discovery treatment

add to watch list Paper trade email alert is off

Aveanna Healthcare Holdings Inc

AVAH | News | $2.25 4.17% 4.0% 150K

|

(0.0% 1d) (-8.2% 1m) (113.3% 1y) (0.0% 2d) (0.0% 3d) (-2.2% 7d) (-100.0% volume)
Earnings Calendar: 2023-11-09
Market Cap: $ 432,852,100
https://www.aveanna.com
Sec Filling | Patents | 2021 employees

Based in Atlanta, Georgia, Aveanna is a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations. Aveanna directly addresses the most pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home, the lower cost care setting preferred by patients.

add to watch list Paper trade email alert is off

Adagene Inc - ADR

ADAG | $2.63 -0.38% -0.38% 5.4K

|

(0.0% 1d) (-7.4% 1m) (78.4% 1y) (0.0% 2d) (0.0% 3d) (1.5% 7d) (-69.41% volume)
Earnings Calendar:
Market Cap: $ 116,026,845
https://www.adagene.com
Sec Filling | Patents | 2020 employees

(China (Mainland)) Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Its proprietary pipeline is comprised of novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.

cancer immunotherapy antibody computational

add to watch list Paper trade email alert is off

FTC Solar Inc

FTCI | $0.396 4.07% 3.91% 410K

|

(0.0% 1d) (-25.0% 1m) (-84.1% 1y) (0.0% 2d) (0.0% 3d) (-8.8% 7d) (-2.49% volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 49,502,305
https://www.ftcsolar.com
Sec Filling | Patents | 221 employees

(US) Founded in 2017 by a group of renewable energy industry veterans, FTC Solar is a fast-growing, global provider of solar tracker systems, technology, software, and engineering services.  Solar trackers significantly increase energy production at solar power installations by dynamically optimizing solar panel orientation to the sun.  FTC Solar’s innovative tracker designs provide compelling performance and reliability, with an industry-leading installation cost-per-watt advantage. 

energy solar renewable optical

add to watch list Paper trade email alert is off

Valneva SE - ADR

VALN | $7.96 -2.09% -2.13% 8.5K

|

(0.0% 1d) (14.5% 1m) (-20.8% 1y) (0.0% 2d) (4.9% 3d) (-4.4% 7d) (71.64% volume)
Earnings Calendar:
Market Cap: $ 552,870,325
https://valneva.com/
Sec Filling | Patents | 2021 employees

(FR) Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden and Vienna, Austria, with other offices in France, Canada and the United States.

vaccine ixchiq chikungunya

add to watch list Paper trade email alert is off

Evaxion Biotech A/S - ADR

EVAX | $4.2 -0.47% -0.48% 31K

|

(0.0% 1d) (39.3% 1m) (212.6% 1y) (0.0% 2d) (3.4% 3d) (2.9% 7d) (Infinity% volume)
Earnings Calendar:
Market Cap: $ 21,903,231
https://www.evaxion-biotech.com
Sec Filling | Patents | 2020 employees

Evaxion Biotech A/S is a clinical-stage AI-immunology™ platform company decoding the human immune system to discover and develop novel immunotherapies to treat cancer and infectious diseases. Based on its proprietary and scalable AI-immunology core technology, Evaxion is developing a broad pipeline of novel product candidates which currently includes three patient-specific cancer immunotherapies, two of which are in Phase I/IIa clinical development. In addition, Evaxion is advancing a portfolio of vaccines to prevent bacterial and viral infections with one program currently in preclinical development against S. aureus (including Methicillin-resistant S. aureus. or MRSA) induced skin and soft tissue infections.

vaccine cancer immunotherapy infectious disease injection batteries skin

add to watch list Paper trade email alert is off

Treace Medical Concepts Inc

TMCI | $10.97 -2.66% -2.73% 380K

|

(0.0% 1d) (-8.8% 1m) (-56.6% 1y) (0.0% 2d) (0.0% 3d) (-4.2% 7d) (Infinity% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 677,453,952
https://www.treace.com
Sec Filling | Patents | 133 employees

(US) Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The Company’s patented Lapiplasty® 3D Bunion Correction™ system is designed to reproducibly correct all three planes of the bunion deformity and address the root cause of the bunion, while allowing patients to get back to their active lives quickly.

3d

add to watch list Paper trade email alert is off

JONES SODA CO

JSDA | $0.2316 -28.3% 150K

|

(0.0% 1d) (0.0% 1m) (9.6% 1y) (0.0% 2d) (9.5% 3d) (9.0% 7d) (326.25% volume)
Earnings Calendar:
Market Cap: $ 23,564,267

Sec Filling | Patents | 21 employees

headquartered in seattle, washington, jones soda co.® (otcqb: jsda) markets and distributes premium beverages under the jones® soda, jones zilch® and jones stripped™ brands. a leader in the premium soda category, jones soda is known for its variety of flavors, high quality ingredients (including cane sugar), and innovative labeling technique that incorporates always-changing photos sent in from its consumers. the diverse product line of jones offers something for everyone – cane sugar soda, zero-calorie soda and an all-naturally sweetened sparkling beverage with only 30 calories and 8 grams of sugar. jones soda is sold primarily through traditional beverage retailers and in many retailers you would not expect to find carbonated beverages across north america. for more information, please visit us at www.jonessoda.com or www.myjones.com.

add to watch list Paper trade email alert is off

IGEN NETWORKS CORP

IGEN | $0.0003 -50.0% 1.4M

|

(0.0% 1d) (25.0% 1m) (-72.2% 1y) (0.0% 2d) (0.0% 3d) (25.0% 7d) (-2.07% volume)
Earnings Calendar:
Market Cap: $ 644,945

Sec Filling | Patents | 10 employees

nimbo tracking is a technology leader in the use of gps (global positioning system) technologies for locating and tracking vehicles, trucks, and heavy equipment. and everything we design and develop is done with our users in mind.

add to watch list Paper trade email alert is off

IIOT-OXYS, Inc.

ITOX 4 | $0.0008 142.86% 10K

|

(0.0% 1d) (-12.5% 1m) (-56.3% 1y) (0.0% 2d) (0.0% 3d) (-30.0% 7d) (-76.66% volume)
Earnings Calendar:
Market Cap: $ 444,012

Sec Filling | Patents | 4 employees

iiot-oxys, inc. identifies, develops, and markets engineered products, software, and services for industrial internet applications. it develops hardware, software, and algorithms that monitor, measure, and predict conditions for energy, structural, agricultural, and medical applications. the company is based in cambridge, massachusetts.

energy

add to watch list Paper trade email alert is off

← Previous
1
2
Next →

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

69%

31%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M

|

EGOX | $0.0515 43.06% 30.1% 330M

|

OLB 4 | $0.33 -14.95% 25.53% 840K

|

Technology Services

NVFY | $2.77 31.28% 23.83% 33M

|

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M

|

Commercial Services

INSG | $3.03 25.21% 20.13% 330K

|

Electronic Technology

KNW 4 | $0.59 -0.71% 18.64% 27K

|

GCTK | $0.8191 22.25% 18.2% 190K

|

WLGS | News | $0.59 18.0% 17.9% 2.3M

|

ASNS | $0.828 21.75% 17.86% 18K

|

Last 48 Hours Insiders Buying

CLSD | $1.29 -2.27% -2.33% 230K

|

Health Technology

| 14:00
CDZI P 25000 | $2.25 0.0% 260K

|

| 14:00
ETST P 39000 | $0.068 -67.14% 43K

|

| 13:30
FNLC P 1275 | $22.97 3.66% 3.53% 21K

|

| 12:30
ADMQ | $0.0532 -40.18% 480K

|

| 10:30
AXR P 2400 | $21.0 -5.28% 0.0% 13K

|

| 21:00
QCRH P 118 | $57.315 3.44% 3.32% 66K

|

| 18:01
VUZI P 7500 | $1.19 -5.56% -5.88% 550K

|

Electronic Technology

| 18:00
RMCF | $3.67 3.38% 3.27% 11K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar